[BSTEAD] YoY Annual (Unaudited) Result on 31-Dec-2008 [#4]

Stock
[BSTEAD] BOUSTEAD HOLDINGS BHD
Announcement Date
26-Feb-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2008
Quarter
31-Dec-2008 [#4]
Profit Trend
YoY- 21.15%
Quarter Report
Latest QR
Upcoming QR
BSTEAD's Result
BSTEAD's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Revenue 8,555,800 6,181,800 5,392,000 7,029,818 5,751,919 4,114,326 1,924,170 28.21%
PBT 831,000 726,200 501,600 678,902 828,814 386,431 271,193 20.50%
Tax -99,100 -101,300 -83,200 -11,228 -174,278 -35,033 -40,746 15.95%
NP 731,900 624,900 418,400 667,674 654,536 351,398 230,447 21.22%
-
NP to SH 610,600 537,500 341,600 578,786 477,736 210,184 190,503 21.41%
-
Tax Rate 11.93% 13.95% 16.59% 1.65% 21.03% 9.07% 15.02% -
Total Cost 7,823,900 5,556,900 4,973,600 6,362,144 5,097,383 3,762,928 1,693,723 29.03%
-
Net Worth 4,891,832 4,207,253 3,053,423 2,852,765 2,266,586 1,922,159 1,706,259 19.17%
Dividend
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Div 403,343 364,628 199,926 191,460 181,326 110,434 93,814 27.50%
Div Payout % 66.06% 67.84% 58.53% 33.08% 37.96% 52.54% 49.25% -
Equity
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Net Worth 4,891,832 4,207,253 3,053,423 2,852,765 2,266,586 1,922,159 1,706,259 19.17%
NOSH 1,034,214 934,945 727,005 638,202 604,423 596,944 586,343 9.91%
Ratio Analysis
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
NP Margin 8.55% 10.11% 7.76% 9.50% 11.38% 8.54% 11.98% -
ROE 12.48% 12.78% 11.19% 20.29% 21.08% 10.93% 11.16% -
Per Share
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
RPS 827.28 661.19 741.67 1,101.50 951.64 689.23 328.16 16.65%
EPS 59.04 57.49 46.99 90.69 79.04 35.21 32.49 10.46%
DPS 39.00 39.00 27.50 30.00 30.00 18.50 16.00 16.00%
NAPS 4.73 4.50 4.20 4.47 3.75 3.22 2.91 8.42%
Adjusted Per Share Value based on latest NOSH - 650,894
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
RPS 422.09 304.97 266.01 346.81 283.77 202.98 94.93 28.21%
EPS 30.12 26.52 16.85 28.55 23.57 10.37 9.40 21.40%
DPS 19.90 17.99 9.86 9.45 8.95 5.45 4.63 27.49%
NAPS 2.4133 2.0756 1.5064 1.4074 1.1182 0.9483 0.8418 19.17%
Price Multiplier on Financial Quarter End Date
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Date 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 29/12/06 30/12/05 -
Price 5.25 4.79 3.08 3.05 5.75 1.72 1.58 -
P/RPS 0.63 0.72 0.42 0.28 0.60 0.25 0.48 4.63%
P/EPS 8.89 8.33 6.55 3.36 7.27 4.88 4.86 10.58%
EY 11.25 12.00 15.26 29.73 13.75 20.47 20.56 -9.55%
DY 7.43 8.14 8.93 9.84 5.22 10.76 10.13 -5.03%
P/NAPS 1.11 1.06 0.73 0.68 1.53 0.53 0.54 12.75%
Price Multiplier on Announcement Date
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Date 27/02/12 25/02/11 25/02/10 26/02/09 29/02/08 27/02/07 15/03/06 -
Price 5.41 4.81 3.03 2.74 4.44 1.94 1.75 -
P/RPS 0.65 0.73 0.41 0.25 0.47 0.28 0.53 3.45%
P/EPS 9.16 8.37 6.45 3.02 5.62 5.51 5.39 9.23%
EY 10.91 11.95 15.51 33.10 17.80 18.15 18.57 -8.47%
DY 7.21 8.11 9.08 10.95 6.76 9.54 9.14 -3.87%
P/NAPS 1.14 1.07 0.72 0.61 1.18 0.60 0.60 11.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment